Prevention of fructose-induced hypertension by dietary vitamins

Clinical Biochemistry

Volumn 37, Issue 1, 2004, Pages 1-9

  Vasdev, Sudesh ^a,b   Longerich, Linda ^a   Gill, Vicki ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Dietary vitamins; Fructose; Hypertension; Sucrose

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; CALCIUM CHANNEL; DIHYDROXYACETONE PHOSPHATE; FRUCTOSE; GLYCERALDEHYDE; GLYCERALDEHYDE 3 PHOSPHATE; MEMBRANE PROTEIN; METHYLGLYOXAL; PYRIDOXINE; SUCROSE; THIOCTIC ACID;

BLOOD PRESSURE; CALCIUM CELL LEVEL; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CLINICAL FEATURE; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; ESSENTIAL HYPERTENSION; GLUCOSE INTOLERANCE; GLYCOLYSIS; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; MEMBRANE CHANNEL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; VASCULAR RESISTANCE; VITAMIN INTAKE;

EID: 0346220398     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2003.09.003     Document Type: Review

References (124)

1. Reaven G.M. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am. J. Med. (Suppl. 2A):1991;7S-12S.
2. Ferrannini E., Buzzigoli G., Bonadonna R.et al. Insulin resistance in essential hypertension. N. Engl. J. Med. 313:1987;350-357.
3. Levy J., Zemel M.B., Sowers J.R. Role of cellular calcium metabolism in abnormal glucose metabolism, and diabetic hypertension. Am. J. Med. (Suppl. 6A):1989;7S-16S.
4. Reiser S., Handler H.B., Gardner L.B., Hallfrisch J.G., Michaelis O.E., Prather E.S. Isocaloric exchange of dietary starch and sucrose in humans: II. Effect on fasting blood insulin, glucose, and glucagon and on insulin and glucose response to a sucrose load. Am. J. Clin. Nutr. 32:1979;2206-2216.
5. Hallfrisch J., Ekkwood K.C., Michaelic O.E., Reiser S., O'Dorisio T.M., Prather E.S. Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men. J. Nutr. 113:1983;1819-1826.
6. Israel K.D., Michaelis O.E., Reiser S., Keeney M. Serum uric acid, inorganic phosphorus, and glutamic-oxalacetic transaminase and blood pressure in carbohydrate-sensitive adults consuming three different levels of sucrose. Ann. Nutr. Metab. 27:1983;425-435.
7. Blakely S.R., Hallfrisch J., Reiser S., Prather E.S. Long-term effects of moderate fructose feeding on glucose tolerance parameters in rats. J. Nutr. 111:1981;307-314.
8. Zavaroni I., Sander S., Scott S., Reaven G.M. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism. 29:1980;970-973.
9. Hwang I.S., Ho H., Hoffman B.B., Reaven G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 10:1987;512-516.
10. Asagami T., Reaven G.M., Tsao P.S. Enhanced monocyte adherence to thoracic aortae from rats with two forms of experimental hypertension. Am. J. Hypertens. 12:1999;890-893.
11. Tobey T.A., Mondon C.E., Zavaroni I., Reaven G.M. Mechanism of insulin resistance in fructose fed rats. Metabolism. 31:1982;608-612.
12. Swislocki A., Tsuzuki A. Insulin resistance and hypertension: glucose intolerance, hyperinsulinemia and elevated free fatty acids in the lean spontaneously hypertensive rat. Am. J. Med. Sci. 306:1993;282-286.
13. Hulman S., Falkner B., Freyvogel N. Insulin resistance in the conscious spontaneously hypertensive rat: euglycemic hyperinsulinemic clamp study. Metabolism. 42:1993;14-18.
14. Lembo G., Iaccarino G., Vecchione C., Rendina V., Trimarco B. Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. Hypertension. 26:1995;290-293.
15. Lieber C.S. Mechanism of ethanol induced hepatic injury. Pharmacol. Ther. 46:1990;1-41.
16. Sorrell M.D., Ruma D.J. The functional implications of acetaldehyde binding to cell constituents. Ann. N. Y. Acad. Sci. 492:1987;50-70.
17. Vasdev S., Barrett B., Longerich L., Ford C.A. Ethanol-induced hypertension: the role of acetaldehyde. Dhalla N.S. Pathophysiology of heart failure. 1996;77-93 Kluwer Academic Publishers, Norwell, MA, USA.
18. Vasdev S., Longerich L., Ford C.A. Role of aldehydes in hypertension. Sharma B.K., Takeda N., Ganguly N.K., Singal P.K. Adaptation biology and medicine. vol. 1:1997;326-339 Narosa Publishing House, New Delhi, India.
19. Vasdev S., Ford C.A., Longerich L., Gadag V., Wadhawan S. Role of aldehydes in fructose induced hypertension. Mol. Cell. Biochem. 181:1998;1-9.
20. Martinez F.J., Rizza J.C., Romero C. High-fructose feeding elicits insulin resistance, hyperinsulinemia, and hypertension in normal mongrel dogs. Hypertension. 23:1994;456-463.
21. Rosenmann E., Teitekbaum A., Cohen A.M. Nephropathy in sucrose-fed rats. Diabetes. 20:1971;803-810.
22. Preuss H.G., Zein M., MacCarthy P., Dipette D., Sabnis S., Knapka J. Sugar-induced blood pressure elevations over the lifespan of three substrains of Wistar rat. J. Am. Coll. Nutr. 17(1):1998;36-47.
23. Clevidence B.A., Srinvasan S.R., Webber L.S., Radhakrishnamurthy B., Dalferes E., Berenson G.S. Serum lipoprotein and blood pressure levels in rhesus monkeys fed sucrose diets. Biochem. Med. 25:1981;186-197.
24. Thorburn A.W., Storlien L.H., Jenkins A.B., Khouri S., Kraegen E.W. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am. J. Clin. Nutr. 49:1989;1155-1163.
25. Preuss H.G., el Zein M., Knapka J., MacArthy P.et al. Blood pressure responses to sucrose ingestion in four rat strains. Am. J. Hypertens. 5:1992;244-250.
26. Reaven G.M., Ho H., Hoffman B.B. Effects of a fructose-enriched diet on plasma insulin and triglyceride concentration in SHR and WKY rats. Horm. Metab. Res. 22(7):1990;363-365.
27. Johnson R.K., Frary C. Choose beverages and foods to moderate your intake of sugars: the 2000 dietary guidelines for Americans - what's all the fuss about. J. Nutr. 131:2001;2766S-2771S.
28. Page L., Friend B. Levels of uses of sugars in the United States. Sipple H.L., McNutt K.W. Sugars in nutrition. 1974;93-107 Academic Press, New York.
29. Hallfrisch J. Metabolic effects of dietary fructose. FASEB J. 4:1990;2652-2660.
30. Cohen A.M. Fats and carbohydrates as factors in atherosclerosis and diabetes in Yemenite jews. Am. Heart J. 65(3):1963;291-293.
31. Grant W.B. Reassessing the role of sugar in the etiology of heart disease. J. Orthomol. Med. 13(2):1998;95-104.
32. Grant W.B. Low-fat, high-sugar diet and lipoprotein profiles. Am. J. Clin. Nutr. 70:1999;1111-1113.
33. Nikkila E.A. Influences of dietary fructose and sucrose on serum triglycerides in hypertriglyceridemia and diabetes. Sipple H.L., McNutt K.W. Sugars in nutrition. 1974;439-448 Academic Press, New York.
34. Beck-Neilson H., Pederson O., Lindskov H.O. Impaired cellular insulin binding and insulin sensitivity induced by high fructose feeding in normal subjects. Am. J. Nutr. 33:1980;273-278.
35. Parks E.J., Hellerstein M.K. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am. J. Clin. Nutr. 71:2000;412-433.
36. Reiser S., Powell A.S., Scholfield D.J., Panda P., Ellwood K.C., Canary J.J. Blood lipids, lipoproteins, apoproteins, and uric acid in men fed diets containing fructose or high-amylose cornstarch. Am. J. Clin. Nutr. 49:1989;832-839.
37. Swanson J.E., Laine D.C., Thomas W., Bantle J.P. Metabolic effects of dietary fructose in healthy subjects. Am. J. Clin. Nutr. 55:1992;851-856.
38. Brandt R.B., Siegel S.A. Methylglyoxal production in human blood. Submolecular biology and cancer. Excerpta Medica, CIBA Foundation Symposium. 67:1979;211-223.
39. Phillips S.A., Mirrlees D., Thornalley P.J. Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor statil. Biochem. Pharmacol. 46:1993;805-811.
40. Leoncini G., Maresca M., Buzzi E. Inhibition of the glycolytic pathway by methylgloxal in human platelets. Cell Biochem. Funct. 7:1989;65-70.
41. Murphy B.J., Washkurak A.W., Tuana B.S. Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups. Biochim. Biophys. Acta. 1052:1990;333-339.
42. Zaidi N.F., Lagenaur C.F., Abramson J.J., Pessah I., Salama G. Reactive disulfides trigger Ca2+ release from sarcoplasmic reticulum via an oxidation reaction. J. Biol. Chem. 264:1989;21725-21736.
43. Brandwein H.J., Lewicki J.A., Murad F. Reversible inactivation of guanylate cyclase by mixed disulfide formation. J. Biol. Chem. 256:1981;2958-2962.
44. Degenhardt T.P., Thorpe S.R., Baynes J.W. Chemical modification of proteins by methylglyoxal. Cell. Mol. Biol. 44:1998;1139-1145.
45. Vasdev S., Ford C.A., Longerich L., Parai S., Gadag V., Wadhawan S. Aldehyde induced hypertension in rats: prevention by N-acetyl cysteine. Artery. 23:1998;10-36.
46. Vasdev S., Mian T., Ford C.A., Longerich L., Parai S. Role of endogenous aldehydes in spontaneously hypertensive and disulfiram-induced hypertensive rats. Nutr. Metab. Cardiovasc. Dis. 6:1996;130-140.
47. Wu L., Juurlink B.H.J. Increased methylglyoxal and oxidative stress in hypertensive vascular smooth muscle cells. Hypertension. 39:2002;809-814.
48. Suzuki K., Islam K.N., Kaneto H., Ookawara T., Taniguchi N. The contribution of fructose and nitric oxide to oxidative stress in hamster islet tumor (HIT) cells through the inactivation of glutathione peroxidase. Electrophoresis. 21:2000;285-288.
49. Kumar K.V., Das U.N. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic. Res. Commun. 19:1993;59-66.
50. Jun T., Ke-yan F., Catalano M. Increased superoxide anion production in humans: a possible mechanism for the pathogenesis of hypertension. J. Hum. Hypertens. 10:1996;305-309.
51. Koska J., Syrova D., Blazicek P.et al. Malondialdehyde, lipofuscin and activity of antioxidant enzymes during physical exercise in patients with essential hypertension. J. Hypertens. 17:1999;529-535.
52. Uysal M., Bulur H., Sener D., Öz H. Lipid peroxidation in patients with essential hypertension. Int. J. Clin. Pharmacol. Ther. Toxicol. 24:1986;474-476.
53. Janero D.R., Burghardt B. Cardiac membrane vitamin E and malondialdehyde levels in heart muscle of normotensive and spontaneously-hypertensive rats. Lipids. 24:1989;33-38.
54. Surya P.P., Das U.N., Koratkar R., Sangeetha S.P., Ramesh G. Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot. Essent. Fatty Acids. 41:1990;27-33.
55. Poli G., Dianzani M.U., Cheeseman K.H., Slater T.F., Lang J., Esterbauer H. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem. J. 227:1985;629-638.
56. Benedetti A., Comporti M., Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta. 620:1980;281-296.
57. Dargel R. Lipid peroxidation - a common pathogenetic mechanism? Exp. Toxicol. Pathol. 44:1992;169-181.
58. Uchida K., Stadtman E.R. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 268(9):1993;6388-6393.
59. Thornalley P.J. Modification of the glyoxalase system in disease processes and prospects for therapeutic strategies. Biochem. Soc. Trans. 21:1993;531-534.
60. Meister A., Anderson M.E., Hwang O. Intracellular cysteine, and glutathione delivery systems. J. Am. Coll. Nutr. 5:1986;137-151.
61. Ferrari R., Ceconi C., Curello S. Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am. J. Med. 91(Suppl. 3C):1991;95-105.
62. Appel L.J., Moore T.J., Obarzabek E., Vollmer W.M.et al. A clinical trial of the effects of dietary patterns on blood pressure. N. Engl. J. Med. 336(16):2001;1117-1124.
63. Sacks F.M., Svetkey L.P., Vollmer W.M.et al. Effects on blood pressure of reduced dietary sodium, and the dietary approaches to stop hypertension (dash) diet. N. Engl. J. Med. 344(1):2001;3-10.
64. Lehninger A.L. Biochemistry: the molecular basis of cell structure and function. Second ed. 1978;698 Worth Publishers, Inc. New York.
65. Smolin L.A., Benevenga N.J. Accumulation of homocyst(e)ine in vitamin B-6 deficiency: a model for the study of cystathionine β-synthase deficiency. J. Nutr. 112:1982;1264-1272.
66. Finkelstein J.D., Chalmers F.T. Pryidoxine effects on cystathionine synthase in rat liver. J. Nutr. 100:1970;467-469.
67. Takeuchi F., Izuta S., Tsubouchi R., Shibata Y. Glutathione levels and related enzyme activities in vitamin B-6 deficient rats fed a high methioinine and low cystine diet. J. Nutr. 121:1991;1366-1373.
68. Vasdev S., Ford C.A., Parai S., Longerich L., Gadag V. Dietary vitamin B6 supplementation attenuates hypertension in spontaneously hypertensive rats. Mol. Cell. Biochem. 200:1999;155-162.
69. Lal K.J., Dakshinamurti K., Thliveris J. The effect of vitamin B6 on the systolic blood pressure of rats in various animal models of hypertension. J. Hypertens. 14:1996;355-363.
70. Bennink H.J.T.C., Schreurs W.H.P. Improvement of oral glucose tolerance in gestational diabetes by pyridoxine. Br. Med. J. 3:1975;13-15.
71. Spellacy W.N., Buhi W.C., Birk S.A. Vitamin B6 treatment of gestational diabetes mellitus. Am. J. Obstet. Gynecol. 127:1977;599-602.
72. Chasan-Taber L., Selhub J., Rosenberg I.H.et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J. Am. Coll. Nutr. 15(2):1996;136-143.
73. Rimm E.B., Willett W.C., Hu F.B.et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 279(5):1998;359-364.
74. Aybak M., Sermet A., Ayyildiz M.O., Karakilcik A.Z. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzeimittel-Forschung. 45:1995;1271-1273.
75. Meister A. Commentary on the antioxidant effects of ascorbic acid and glutathione. Biochem. Pharmacol. 44:1992;1905-1915.
76. Paolisso G., D'Amore A., Balbi V.et al. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetes. Am. J. Physiol. 266(Endocrinol. Metab. 29):1994;E261-E268.
77. Paolisso G., Balbi V., Volpe C.et al. Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J. Am. Coll. Nutr. 14:1995;387-392.
78. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J. Biol. Chem. 269:1994;9397-9400.
79. Johnston C.S., Meyer C.G., Srilakshmi J.C. Vitamin C elevates red blood cell glutathione in healthy adults. Am. J. Clin. Nutr. 58:1993;103-105.
80. Janero D.R., Burghadt B. Cardiac membrane vitamin E and malon-dialdehyde levels in heart muscle of normotensive and spontaneously-hypertensive rats. Lipids. 24:1989;33-38.
81. Uysal M., Bulur H., Sener D., Öz H. Lipid peroxidation in patients with essential hypertension. Int. J. Clin. Pharmacol. Ther. Toxicol. 24:1986;474-476.
82. Moran J.P., Cohen L., Greene J.M.et al. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am. J. Clin. Nutr. 57:1993;213-217.
83. Ness A.R., Chee D., Elliott P. Vitamin C and blood pressure - an overview. J. Hum. Hypertens. 11:1997;343-350.
84. Block G., Mangels A.R., Norkus E.P., Patterson B.H., Levander O.A., Taylor P.R. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension. 37:2001;261-267.
85. Duffy S.J., Gokce N., Holbrook M. Treatment of hypertension with ascorbic acid. The Lancet. 354:1999;2048-2049.
86. Hajjar I.M., George V., Sasse E.A., Kochar M.S. A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am. J. Ther. 9:2002;289-293.
87. Trout D.L. Vitamin C and cardiovascular risk factors. Am. J. Clin. Nutr. 53:1991;322S-325S.
88. Nyyssönen K., Parviainen M.T., Salonen R., Tuomilehto J., Salonen J.T. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ. 314:1997;634-638.
89. Vasdev S., Ford C.A., Parai S., Longerich L., Gadag V. Dietary vitamin C supplementation lowers blood pressure in spontaneously hypertensive rats. Mol. Cell. Biochem. 218:2001;97-103.
90. Yoshioka M., Aoyama K., Matsushita T. Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats (SH rats). Int. J. Vitam. Nutr. Res. 55:1985;301-307.
91. Ziemlanski S., Wartanowicz M., Potrzebnicka K.et al. Effect of exogenous ascorbic acid on experimental hypertension and mineral balance in rats fed low- and high-fat diets. Nutrition. 7:1991;131-135.
92. Akpaffiong M.J., Taylor A.A. Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats. Am. J. Hypertens. 11:1998;1450-1460.
93. Vasdev S., Longerich L., Singal P. Nutrition and hypertension. Nutr. Res. 22:2002;111-123.
94. Vasdev S., Gill V., Parai S., Longerich L., Gadag V. Dietary vitamin E and C supplementation prevents fructose induced hypertension in rats. Mol. Cell. Biochem. 241:2002;107-114.
95. Tappel A.L. Biological antioxidant protection against lipid peroxidation damage. Am. J. Clin. Nutr. 23:1970;1137-1139.
96. Burton G.W., Foster D.O., Perly B., Slater T.F., Smith I.C.P., Ingold K.U. Biological antioxidants. Philos. Trans. R. Soc. Lond. [Biol.]. 311:1985;565-578.
97. Beamish R.E. Vitamin E - then and now. Can. J. Cardiol. 9(1):1993;29-30.
98. Grey K.F., Puska P., Jordan P., Moser U.K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53:1991;326S-334S.
99. Donnan P.T., Thomson M., Fowkes F.G.R., Prescott R.J., Housley E. Diet as a risk factor for peripheral arterial disease in the general population: the Edinburgh artery study. Am. J. Clin. Nutr. 57:1993;917-921.
100. Paolisso G., D'Amore A., Giugliano D., Ceriello A., Varricchio M., D'Onofrio F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am. J. Clin. Nutr. 57:1993;650-656.
101. Barbagallo M., Dominguez L.J., Tagliamonte M.R., Resnick L.M., Paolisso G. Effect of vitamin E and glutathione on glucose metabolism. Role of magnesium. Hypertension. 34(part 2):1999;1002-1006.
102. Costagliola C., Libondi T., Menzione M., Rinaldi E., Auricchio G. Vitamin E and red blood cell glutathione. Metabolism. 34(8):1985;712-714.
103. Sharma A., Kharb S., Chugh S.N., Kakkar R., Singh G.P. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism. 49(2):2000;160-162.
104. Paolisso G., Giugliano D., Pizza G.et al. Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care. 15(1):1992;1-7.
105. Wen Y., Killalea S., McGettigan P., Feely J. Lipid peroxidation and antioxidant vitamins C and E in hypertensive patients. Irish J. Med. Sci. 165:1996;210-212.
106. Bendich A., Gabriel E., Machlin L.J. Differences in vitamin E levels in tissues of the spontaneously hypertensive and Wistar-Kyoto rats (41560). Proc. Soc. Exp. Biol. Med. 172:1983;297-300.
107. Ito H., Torii M., Suzuki T. A comparative study on defense systems for lipid peroxidation by free radicals in spontaneously hypertensive and normotensive rat myocardium. Comp. Biochem. Physiol. B. 103(No. 1):1992;37-40.
108. Akyol D., Mungan T., Görkemli H., Nuhoglu Maternal levels of vitamin E in normal and preeclamptic pregnancy. Arch. Gynecol. Obstet. 263:2000;151-155.
109. Boshtam M., Rafiei M., Sadeghi K., Sarraf-Zadegan N. Vitamin E can reduce blood pressure in mild hypertensives. Int. J. Vitam. Nutr. Res. 72:2002;309-314.
110. Vasdev S., Gill V., Parai S., Longerich L., Gadag V. Dietary vitamin E supplementation lowers blood pressure in spontaneously hypertensive rats. Mol. Cell. Biochem. 238:2003;111-117.
111. Emmert D.H., Kirchner J.T. The role of vitamin E in the prevention of heart disease. Arch. Fam. Med. 8(6):1999;537-542.
112. α-Lipoic acid. Altern. Med. Rev. 3(4):1998;308-310.
113. Packer L., Witt E.H., Tritschler H.J. Alpha-lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 19(2):1995;227-250.
114. Han D., Handelman G., Marcocci L.et al. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. BioFactors. 6:1997;321-338.
115. Busse E., Zimmer G., Schopohl B., Kornhuber B. Influence of α-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittel-Forschung. 42:1992;829-831.
116. Packer L., Roy S., Sen C.K. α-Lipoic acid: a metabolic antioxidant and potential redox modulator of transcription. Adv. Pharmacol. 38:1999;79-101.
117. Jacob S., Henriksen E.J., Schiemann A.L.et al. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittel-Forschung. 45:1995;872-874.
118. Konrad T., Vicini P., Kusterer A., Hoflich A., Assadkhani A. α-Lipoic acid treatment decreases serum lactate and pyruvate concentrations, and improves glucose effectiveness in lean, and obese patients with type 2 diabetes. Diabetes Care. 22:1999;280-287.
119. Jacob S., Streeper R.S., Fogt D.L.et al. The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes. 45:1996;1024-1029.
120. Koçak G., Aktan F., Canbolat O.et al. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr. Metab. 13:2000;308-318.
121. Takaoka M., Kobayashi Y., Yuba M., Ohkita M., Matsumura Y. Effects of α-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Eur. J. Pharmacol. 424:2001;121-129.
122. Coombes J.S., Powers S.K., Hamilton K.L. Improved cardiac performance after ischemia in aged rats supplemented with vitamin E and α-lipoic acid. Am. J. Physiol. 279(Issue 6):2000;R2149-R2155.
123. Vasdev S., Ford C.A., Parai S., Longerich L., Gadag V. Dietary α-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J. Hypertens. 18:2000;567-573.
124. Vasdev S., Ford C.A., Parai S., Longerich L., Gadag V. Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. Nutr. Metab. Cardiovasc. Dis. 10:2000;339-346.